December 13, 2016 04:59 PM EST
Pharma

It’s the law: Oba­ma signs wide­ly pop­u­lar 21st Cen­tu­ry Cures Act

John Carroll

Editor & Founder

In the end, the 21st Cen­tu­ry Cures Act looked like an old-time bill, laden with ex­tras for can­cer re­search, an­tibi­otics, the opi­oid epi­dem­ic and even …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Up­dat­ed: No­var­tis claims best earn­ings in years, val­i­dat­ing shift to pure-play strat­e­gy

Ab­b­Vie ex­ec­u­tives bask in Skyrizi, Rin­voq suc­cess­es as the drugs take up Hu­mi­ra's man­tle

Ver­tex's non-opi­oid pain drug is ap­proved by FDA, bring­ing first of new class to mar­ket

Roche sep­a­rates CFO, in­for­mat­ics posts; Lil­ly ex­ecs land at Kail­era, Neu­ro­crine

Dai­ichi Sankyo taps new CEO, aims to build up ADC fran­chise

sponsored

Why the pre­mier re­cruit­ment agency in the world is giv­ing up re­cruit­ing, and spon­sors should, too

A service from the Financial Times